Furthermore, Squitti et al. conducted a meta-analysis of data on copper concentrations in the serum, plasma, and brain of AD patients, finding decreased copper concentrations in the brains of AD patients with increased total copper and NCC concentrations in the serum of AD patients, supporting the copper hypothesis of AD [88]. This evidence concerns the gene SLC12A3 and Alzheimer disease.